Neha Chandramani Meshram

Neha Chandramani Meshram

Director Director DIN 07724578
DIN 07724578 First appointment Feb 2017 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Neha Chandramani Meshram

Data last updated:

Neha Chandramani Meshram has 9 years in corporate governance. Formerly with 1 company, such as Impaler Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07724578
Primary Designation Director
First Appointment 20 Feb 2017
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Feb 20172017₹5.4 Lakh (FY 2020)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Impaler Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neha Chandramani Meshram

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neha Chandramani Meshram

Neha Chandramani Meshram has 9 years in corporate governance. Formerly with 1 company, such as Impaler Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Neha Chandramani Meshram has expertise in General Business.

Neha Chandramani Meshram has 9 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available